TipRanks - 2024-12-19 11:33
An update from Reviva Pharmaceuticals Holdings ( (RVPH) ) is now available. Reviva Pharmaceuticals announced an underwriting agreement with Citizens JMP Securities for a public offering, raising $18 million through the sale of common stock and warrants. The net proceeds are intended for research and development, working capital, and general corporate purposes. This move aims to strengthen Reviva’s financial position and support its drug development activities. More about Reviva Pharmaceuticals H